GE HealthCare Stock: $32.4B Market Cap, Will It Climb?
Wall Street analysts have mixed predictions for GE HealthCare, with expected EPS growth of 7.4% to $4.93 for the fiscal year ending in December 2026, but its shares have underperformed the broader market over the past year
GE HealthCare Technologies Inc. has a market capitalization of $32.4 billion, but its shares have underperformed the broader market over the past year, gaining marginally while the S&P 500 Index has climbed nearly 22.4%.
The company reported its Q2 FY2026 earnings on July 29, with revenues growing 5.7% to $5.3 billion and adjusted EPS rising 6.6% to $1.13. Analysts expect GEHC's diluted EPS to rise 7.4% year-over-year to $4.93 for the fiscal year ending in December 2026.
In comparison, other companies such as UnitedHealth Group Incorporated have outpaced the broader market over the past year, surging 62.9% compared to the S&P 500 Index's 21.3% surge. On the other hand, Yum! Brands' shares have lagged behind the broader market over the past year, growing 2.9% compared to the S&P 500 Index's 21.3% surge.
## What's Next The mixed predictions from Wall Street analysts reflect the uncertainty surrounding the performance of various stocks, including GE HealthCare, Fox Corporation, Welltower, Alliant Energy, D.R. Horton, Fiserv, UnitedHealth Group, Yum! Brands, Stanley Black & Decker, and News Corporation.
The stakes are high, as investors look to these companies for growth and returns. The healthcare and technology sectors, in particular, are closely watched, given their potential for innovation and disruption. As the global economy continues to evolve, the performance of these companies will be crucial in determining the direction of the market.
## Why It Matters The performance of GE HealthCare and other companies has significant implications for investors and the broader market. With a market capitalization of $32.4 billion, GE HealthCare is a major player in the healthcare technology sector. Its expected EPS growth of 7.4% to $4.93 for the fiscal year ending in December 2026 is a positive sign, but its underperformance over the past year raises concerns.
The company's Q2 FY2026 earnings report showed promising results, with revenues growing 5.7% to $5.3 billion and adjusted EPS rising 6.6% to $1.13. However, the company's shares have underperformed the broader market over the past year, gaining marginally while the S&P 500 Index has climbed nearly 22.4%. This disparity highlights the challenges facing the company and the need for it to regain momentum in the market.
